California Public Employees Retirement System X4 Pharmaceuticals, Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$6.49 - $9.56 $210,925 - $310,700	-32,500 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$7.98 - $10.44 $259,350 - $339,300	32,500 New	32,500 $303,000

Others Institutions Holding XFOR

# of Institutions

106

Shares Held

103M

Call Options Held

206K

Put Options Held

291K

Bain Capital Life Sciences Investors, LLC Boston, MA

16.9M
Shares

$9.81 Million
3.55% of portfolio
Nea Management Company, LLC Timonium, MD

15M
Shares

$8.69 Million
1.46% of portfolio
Black Rock Inc. New York, NY

8.74M
Shares

$5.07 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.83M
Shares

$4.54 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

7.13M
Shares

$4.14 Million
0.22% of portfolio

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $39.8M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account